Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 Feb;85(2):110-8.

[Experimental studies on combined chemotherapy with hyperthermia and ethanol for advanced esophageal cancer. II. Effects of combined treatments on tumor growth in tumor-bearing mice]

[Article in Japanese]
  • PMID: 6205247

[Experimental studies on combined chemotherapy with hyperthermia and ethanol for advanced esophageal cancer. II. Effects of combined treatments on tumor growth in tumor-bearing mice]

[Article in Japanese]
W Takiyama. Nihon Geka Gakkai Zasshi. 1984 Feb.

Abstract

The combined effects of local hyperthermia, bleomycin and ethanol were investigated using Lewis lung carcinoma (3LL) in female C57BL/6 mice and FM3A tumors in female C3H/He mice. The combined treatments were performed on days 4 and 7 or on days 4, 7 and 10 after tumor implantation. Hyperthermia at 43 degrees C for 60 min or 15 mg/kg of bleomycin resulted in mild reductions of tumor growth, respectively, whereas hyperthermia at 41 degrees C for 60 min alone did not show antitumor effects. Synergistic effects were observed with 43 degrees C hyperthermia and bleomycin. Furthermore the effects were enhanced by the combined use of ethanol (10% ethanol, 0.05 ml, i.t.). The antitumor effects of combined treatments of 41 degrees C hyperthermia and bleomycin were not so remarkable as those of 43 degrees C hyperthermia and bleomycin. In the combination of 41 degrees C hyperthermia, bleomycin and ethanol, marked increase of antitumor effects was observed particularly in 3LL tumor. A possible application of these findings to clinical therapy for advanced esophageal cancer was discussed.

PubMed Disclaimer

Similar articles

Cited by

Publication types

LinkOut - more resources